New Study Reviews Focal Irreversible Electroporation (IRE) in Localised Prostate Cancer

A recent editorial in European Urology reviews findings from the multicentre PRESERVE study, which investigated the use of focal irreversible electroporation (IRE) in men with localised intermediate-risk prostate cancer. The publication discusses key considerations such as patient selection, imaging approaches, follow-up protocols and the emerging clinical evidence that informs ongoing evaluation of focal therapy in prostate cancer care.

Reference:
Scheltema MJV, Stricker PD. Prospective Multicentre Validation of Focal Irreversible Electroporation as an Attractive Treatment Option for Localised Intermediate-risk Prostate Cancer. European Urology. October 2025. DOI: 10.1016/j.eururo.2025.10.003.

To learn more about this study, visit: European Urology